$NIVF is +113.33% before the bell, and the company's most recent press release is 85 days old.
That July release carried a Big Four valuation of US$19 million for a planned UAE cell-sorting and cytometry leasing business. Going into today, the market valued the entire company at about $654K on a 3M-share float.
A valuation of something planned is an opinion on letterhead. It isn't revenue, and nothing in this morning's feed updates it. Whatever doubled the stock, the move is unexplained by the available news.
This ticker's own history: in 19 prior sessions where it opened with a gap-up of 5% or more, it closed below the open 53% of the time and above it 42% of the time. The median open-to-close was -1.52%.